Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer

AbstractBackgroundHigh-grade prostate cancer (PCa) has a poor prognosis, and up to 15% of patients worldwide experience lymph node invasion (LNI). To further improve the prediction lymph node invasion in prostate cancer, we adopted risk scores of the genes expression based on the nomogram in guideli